Going to the ECRM Branded Rx and Vaccine Program June 12-15 in Charlotte, NC? LSPediA is delighted to meet with you there. Our Vice President of Solutions Michael Ventura…
Learn More
LSPediA announced the release of OneScan version 5.3 via a press release that went out on May 10, on 2022. OneScan is LSPediA’s flagship cloud solution suite offering the industry’s…
LSPediA held its April 2022 Customer Advisory Board meeting on April 26 to great success. It was well-attended, and attendees received up to date information about product releases, VRS/EPCIS benchmarks,…
April 4, West Bloomfield, Michigan – LSPediA Inc., a leading cloud solution provider for the pharmaceutical industry, today announced that Justin Winkelman joins LSPediA’s Leadership Team as Director of Operations. …
Helping customers to succeed is LSPediA’s core value and guiding principle. As pharmaceutical companies sprint to the 2023 DSCSA requirement by the FDA, LSPediA releases OneScan 5.2, a cloud solution…
The time is now to be planning for DSCSA implementation to meet the FDA’s 2023 requirement. LSPediA can help! So whether you are still in the planning stages or hit…
With 2021 coming to a close in two weeks and the holidays right around the corner, LSPediA held its year-end Customer Advisory Board Meeting virtually on Tuesday, Dec. 14. CEO Riya Cao directed the…
The coronavirus outbreak has affected virtually every aspect of our daily lives at some point in the last 18 months. In the midst of so much political and sociological turmoil,…
Save the Date! LSPediA will hold the next Customer Advisory Board (CAB) Meeting on Tuesday, Dec. 14 at 11AM EST. We are excited to announce that our CEO Riya Cao…
Cardinal Health Investigator for EPCIS workshop series will take place monthly on the third Wednesday of each month. During the workshop, Cardinal Health and LSPEDIA will provide an overview of EPCIS and the streamlined process to ramp up EPCIS testing. This webinar will address the EPCIS data exchange and harmonization of EPCIS exceptions workflow towards meeting the November 2023 Drug Supply Chain Security Act (DSCSA) requirement.